Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects.
COVID-19
cardiac impairment
electrocardiography
mortality
Journal
Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414
Informations de publication
Date de publication:
31 Jan 2023
31 Jan 2023
Historique:
received:
28
12
2022
accepted:
26
01
2023
entrez:
24
2
2023
pubmed:
25
2
2023
medline:
25
2
2023
Statut:
epublish
Résumé
COVID-19 has threatened the capability of receiving and allocating patients in emergency departments (EDs) all over the world. This is a retrospective cohort study to explore the role of a simple procedure like an ECG to screen for the severity of COVID-19 on admission to the ED. For this study, 548 consecutive patients were enrolled in a multicenter international registry and stratified upon ECG on admission with a simple distinction between normal vs. abnormal rhythm. Among patients in the abnormal ECG group were those with heart rates higher than 100 beats per minute and/or atrial fibrillation. Survival in patients with normal ECG rhythm was deemed below 75% after 58 days and then stabilized, while survival in patients with abnormal ECG rhythm was deemed below 75% after 11 days and below 50% after 21 days. A multivariate analysis including abnormal rhythm, gender, age, diabetes, obesity, respiratory failure during hospitalization, heart failure during hospitalization, and abnormal rhythm was an independent predictor of death (HR 7.20 95% CI 3.63-14.28,
Identifiants
pubmed: 36826554
pii: jcdd10020058
doi: 10.3390/jcdd10020058
pmc: PMC9967030
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JACC Clin Electrophysiol. 2021 Apr;7(4):485-493
pubmed: 33358667
Cells. 2022 Jan 12;11(2):
pubmed: 35053369
PLoS One. 2021 Dec 14;16(12):e0261315
pubmed: 34905575
Lancet Haematol. 2020 Sep;7(9):e671-e678
pubmed: 32659214
BMC Emerg Med. 2021 Nov 19;21(1):141
pubmed: 34798827
Clin Infect Dis. 2021 Dec 6;73(11):e4031-e4038
pubmed: 33098645
J Clin Med. 2021 Jun 29;10(13):
pubmed: 34209964
Clin Cardiol. 2021 Jul;44(7):963-970
pubmed: 33973673
Anatol J Cardiol. 2021 Nov;25(11):811-820
pubmed: 34734815
Lancet. 2021 Aug 14;398(10300):599-607
pubmed: 34332652
J Am Heart Assoc. 2022 Jul 5;11(13):e024530
pubmed: 35730631
Nat Med. 2022 Feb;28(2):410-422
pubmed: 34907393
Front Med (Lausanne). 2021 Jan 20;7:625176
pubmed: 33553217
Brain Res. 1987 May;430(1):113-26
pubmed: 3297256
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Cureus. 2020 Aug 3;12(8):e9540
pubmed: 32905500
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184
pubmed: 32750108
J Clin Med. 2021 Aug 13;10(16):
pubmed: 34441862
J Card Fail. 2020 Jul;26(7):626-632
pubmed: 32544622
Heart Rhythm O2. 2021 Mar 23;2(3):304-308
pubmed: 34337582
N Engl J Med. 2021 Nov 18;385(21):1941-1950
pubmed: 34706189
Immunol Res. 2021 Apr;69(2):205-211
pubmed: 33786700
J Transl Int Med. 2021 Sep 28;9(3):177-184
pubmed: 34900628
Pathog Glob Health. 2022 Jul;116(5):297-304
pubmed: 35138229
PLoS One. 2021 Oct 28;16(10):e0258841
pubmed: 34710127
N Engl J Med. 2022 Apr 14;386(15):1397-1408
pubmed: 35172054
EMBO J. 2020 May 18;39(10):e105114
pubmed: 32246845